Showing results (381-390 of 847) with videos related to
Sort By:
Pageof 85
JNCI Cancer Spectrum|June 16, 2023
Career disruption and limitation of financial earnings due to cancerDinesh Pal Mudaranthakam, Dorothy Hughes, Peggy Johnson, et al.JNCI Cancer Spectrum|June 30, 2023
Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort studyCasey Crump, Pär Stattin, James D Brooks, et al.JNCI Cancer Spectrum|February 21, 2026
Oncologist perspectives on the time toxicity of palliative systemic treatments for advanced cancerSamuel X Stevens, Isaac Y Addo, Ella El-Katateny, et al.JNCI Cancer Spectrum|March 18, 2026
Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over five-year follow-upKathleen Van Dyk, Wanting Zhai, Tim A Ahles, et al.JNCI Cancer Spectrum|May 4, 2026
Financial reimbursement for clinical trial participation costs: a pilot feasibility studyCourtney P Williams, Nicole L Henderson, Nusrat Jahan, et al.JNCI Cancer Spectrum|May 1, 2026
Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32Pamela J Goodwin, Marguerite Ennis, Bingshu E Chen, et al.JNCI Cancer Spectrum|April 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancerErika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi, et al.JNCI Cancer Spectrum|May 7, 2026
Sequential chemo-durvalumab, reduced dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial)Francesco Agustoni, Jessica Saddi, Diego Luigi Cortinovis, et al.JNCI Cancer Spectrum|April 12, 2026
Artificial intelligence-based multi-modal multi-tasks analysis of thyroid ultrasound image features predicts thyroid cancer: a multicenter studyYu Gui, Xuerui Zhang, Yun He, et al.JNCI Cancer Spectrum|April 25, 2026
Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancerYehoda M Martei, Kan Chen, Modesty Obasohan, et al.Pageof 85